Skip to content

Combined drug and alcohol treatment trial

Combined Drug and Alcohol Treatment Trial (COMDAT): a two-arm interventional multicentre parallel-group superiority trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN88025085
Enrollment
300
Registered
2020-09-23
Start date
2020-10-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol and drug use disorders Mental and Behavioural Disorders Mental and behavioural disorders due to use of alcohol

Interventions

A parallel-group, two-arm, superiority trial comparing MOVE individual treatment (i) with MOVE group treatment (g) for alcohol use disorder and drug use disorder. Participants will be asked to answe

Sponsors

Aarhus University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Participants aged above 17 years seeking treatment for a substance use disorder, who are willing to give consent 2. Participants must be able to speak and read Danish

Exclusion criteria

Exclusion criteria: 1. Patients with an ongoing or recent (< 1 month) treatment episode for substance use disorders 2. Patients with opioid use disorders 3. Patients with ongoing delusions/psychosis, threatening/aggressive behavior and/or severe cognitive impairment

Design outcomes

Primary

MeasureTime frame
1. Substance intake (last week and last month) measured in all attended sessions using the TEM screening (Trivsels og Effekt Monitorering) that consists of 17 items of which eight are related to substance use. The eight substance-related items in TEM will be used to monitor substance use in the last seven days before each counseling session. In addition, the client will be asked about substance use within the last month (AdultMap) at enrolment and 3 and 9 months after enrolment 2. Number of sessions attended is measured consecutively by the clinician responsible for the participant's treatment course 3. Dropout from treatment as defined by being discharged for any reason other than having completed the treatment program

Secondary

MeasureTime frame
1. Psychological wellbeing within the last month measured at enrolment and 3 and 9 months after enrollment (AdultMap) and last week using three items as part of the TEM screening in every counselling session 2. Everyday functioning (concentration, planning, keeping appointments, sleep, eating habits, cleaning etc) within the last month measured at enrolment and 3 and 9 months after enrolment (AdultMap) and within the last week using TEM screening in every counselling session 3. Illegal activities within the last month at enrolment and 3 and 9 months after enrolment (AdultMap) 4. Employment/education activities within the last month and 3 and 9 months after enrolment (AdultMap) (added 29/09/2020) Outcome measures related to feasibility/acceptability: 5. Audio recordings of all treatment sessions 6. Qualitative interviews about participants experiences of treatment at nine months follow-up. 7. Survey of the counselors treatment experiences that focuses on the feasibility of the treatment. 8. Compare reason of discharge from treatment with the two national registers of drug and alcohol users admitted to treatment (Case-control)

Countries

Denmark

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 14, 2026